DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 10 of 16 descriptions
Filter by
Reset
No.
薬物名（臨床試験情報から抽出）
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
指定難病告示番号
1
The effectiveness of
Xeljanz
in rheumatoid arthritis patients
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
2
Tofacitinib (
Xeljanz
)
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
3
Tofacitinib (
Xeljanz
®)
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
4
Tofacitinib (
Xeljanz
®) 11mg Prolonged Release Tablet
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
46
46
5
Tofacitinib 10 MG [
Xeljanz
]
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
97
97
6
Tofacitinib 5 MG [
Xeljanz
]
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
2件:
46
46
,
50
7
Tofacitinib 5mg Oral Tablet [
Xeljanz
] 16 week trial
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
84
84
8
XELJANZ
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
4件:
46
46
,
97
,
107
,
271
9
XELJANZ
(tofacitinib)
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
65
65
10
XELJANZ
-
1件:
Tofacitinib
Tofacitinib
(Synonym:
Xeljanz
XR)
1件:
D09970
D09970
4件:
JAK1
JAK1
,
JAK2
,
JAK3
,
TYK2
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical carcinogenesis - receptor activation
,
Chemokine signaling pathway
,
Cholinergic synapse
,
Coronavirus disease - COVID-19
,
EGFR tyrosine kinase inhibitor resistance
,
Epstein-Barr virus infection
,
Growth hormone synthesis, secretion and action
,
Hepatitis B
,
Hepatitis C
,
Herpes simplex virus 1 infection
,
Human T-cell leukemia virus 1 infection
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Influenza A
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
Leishmaniasis
,
Lipid and atherosclerosis
,
Measles
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-small cell lung cancer
,
Osteoclast differentiation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Primary immunodeficiency
,
Prolactin signaling pathway
,
Signaling pathways regulating pluripotency of stem cells
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Toxoplasmosis
,
Tuberculosis
,
Viral carcinogenesis
💬
37件:
AGE-RAGE signaling pathway in diabetic complications
,
Adipocytokine signaling pathway
,
Chemical
...
1件:
97
97